Crucial role of the melanocortin receptor MC1R in experimental colitis

Gut

Volumn 55, Issue 10, 2006, Pages 1415-1422

  Maaser, Christian ^a   Kannengiesser, K ^a   Specht, C ^a   Lugering A ^a   Brzoska, T ^a   Luger, T A ^a   Domschke, W ^a   Kucharzik, T ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MELANOCORTIN 1 RECEPTOR; MYELOPEROXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CITROBACTER RODENTIUM; COLITIS; CONTROLLED STUDY; ENZYME ACTIVITY; FRAMESHIFT MUTATION; HEMATOPOIETIC CELL; HISTOLOGY; INFLAMMATION; INTESTINE EPITHELIUM CELL; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WEIGHT REDUCTION; WILD TYPE;

ALPHA-MSH; ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CHIMERA; CITROBACTER; COLITIS; ENTEROBACTERIACEAE INFECTIONS; FEMALE; IMMUNOBLOTTING; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL; PEROXIDASE; RECEPTOR, MELANOCORTIN, TYPE 1;

EID: 33748994935     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.083634     Document Type: Article

References (50)

1. Chretien M, Seidah NG. Chemistry and biosynthesis of pro- opiomelanocortin. ACTH, MSHs, endorphins and their related peptides. Mol Cell Biochem 1981;34:101-27.
2. Thody AJ, Ridley K, Penny RJ, et al. MSH peptides are present in mammalian skin. Peptides 1983;4:813-16.
3. Wintzen M, Gilchrest BA. Proopiomelanocortin, its derived peptides, and the skin. J Invest Dermatol 1996;106:3-10.
4. Luger TA, Brzoska T, Scholzen TE, et al. The role of alpha-MSH as a modulator of cutaneous inflammation. Ann NY Acad Sci 2000;917:232-8.
5. Bhordwaj RS, Luger TA. Proopiomelanocortin production by epidermal cells: evidence for an immune neuroendocrine network in the epidermis. Arch Dermatol Res 1994;287:85-90.
6. Botchkarev VA, Botchkareva NV, Slominski A, et al. Developmentally regulated expression of alpha-MSH and MC-1 receptor in C57BL/6 mouse skin suggests functions beyond pigmentation. Ann NY Acad Sci 1999;885:433-9.
7. Scholzen TE, Kalden DH, Brzoska T, et al. Expression of proopiomelanocortin peptides in human dermal microvascular endothelial cells: evidence for a regulation by ultraviolet light and interleukin-1. J Invest Dermatol 2000;115:1021-8.
8. Neumann Andersen G, Nagaeva O, Mandrika I, et al. MC(1) receptors are constitutively expressed on leucocyte subpopulations with antigen presenting and cytotoxic functions. Clin Exp Immunol 2001;126:441-6.
9. Slominski A, Wortsman J, Luger T, et al. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev 2000;80:979-1020.
10. Lipton JM, Zhao H, Ichiyama T, et al. Mechanisms of antiinflammatory action or alpha-MSH peptides. In vivo and in vitro evidence. Ann NY Acad Sci 1999;885:173-82.
11. Luger TA, Bhardwaj RS, Grabbe S, et al. Regulation of the immune response by epidermal cytokines and neurohormones. J Dermatol Sci 1996;13:5-10.
12. Cutuli M, Cristiani S, Lipton JM, et al. Antimicrobial effects of alpha-MSH peptides. J Leukoc Biol 2000;67:233-9.
13. Slominski A, Tobin DJ, Shibahara S, et al. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev 2004;84:1155-228.
14. Star RA, Rajora N, Huang J, et al. Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulating hormone. Proc Natl Acad Sci USA 1995;92:8016-20.
15. Rajora N, Ceriani G, Catania A, et al. alpha-MSH production, receptors, and influence on neopterin in a human monocyte/macrophage cell line. J Leukoc Biol 1996;59:248-53.
16. Watanabe T, Hiltz ME, Catania A, et al. Inhibition of IL-1 beta-induced peripheral inflammation by peripheral and central administration of analogs of the neuropeptide alpha-MSH. Brain Res Bull 1993;32:311-14.
17. Catania A, Rajora N, Capsoni F, et al. The neuropeptide alpha-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro. Peptides 1996;17:675-9.
18. Rajora N, Boccoli G, Catania A, et al. alpha-MSH modulates experimental inflammatory bowel disease. Peptides 1997;18:381-5.
19. Catania A, Gatti S, Colombo G, et al. Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol Rev 2004;56:1-29.
20. Bhardwaj R, Becher E, Mahnke K, et al. Evidence for the differential expression of the functional alpha-melanocyte-stimulating hormone receptor MC-1 on human monocytes. J Immunol 1997;158:3378-84.
21. Becher E, Mahnke K, Brzoska T, et al. Human peripheral blood-derived dendritic cells express functional melanocortin receptor MC-1R. Ann NY Acad Sci 1999;885:188-95.
22. Mountjoy KG. The human melanocyte stimulating hormone receptor has evolved to become "super-sensitive" to melanocortin peptides. Mol Cell Endocrinol 1994;102:R7-11.
23. Hartmeyer M, Scholzen T, Becher E, et al. Human dermal microvascular endothelial cells express the melanocortin receptor type 1 and produce increased levels of IL-8 upon stimulation with alpha-melanocyte-stimulating hormone. J Immunol 1997;159:1930-7.
24. Adachi S, Nakano T, Vliagoftis H, et al. Receptor-mediated modulation of murine mast cell function by alpha-melanocyte stimulating hormone. J Immunol 1999;163:3363-8.
25. Bohm M, Eickelmann M, Stander S, et al. Expression of melanocortin receptors on cutaneous fibroblastic cells - collagen and beyond. Exp Dermatol 2005;14:157.
26. Colombo G, Buffa R, Bardella MT, et al. Anti-inflammatory effects of alpha-melanocyte-stimulating hormone in celiac intestinal mucosa. Neuroimmunomodulation 2002;10:208-16.
27. Brzoska T, Kalden DH, Scholzen T, et al. Molecular basis of the alpha-MSH/ IL-1 antagonism. Ann NY Acad Sci 1999;885:230-8.
28. Yoon SW, Goh SH, Chun JS, et al. alpha-Melanocyte-stimulating hormone inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production in leukocytes by modulating protein kinase A, p38 kinase, and nuclear factor kappa B signaling pathways. J Biol Chem 2003;278:32914-20.
29. Manna SK, Aggarwal BB. Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-kappa B activation induced by various inflammatory agents. J Immunol 1998;161:2873-80.
30. Kalden DH, Scholzen T, Brzoska T, et al. Mechanisms of the antiinflammatory effects of alpha-MSH. Role of transcription factor NF-kappa B and adhesion molecule expression. Ann NY Acad Sci 1999;885:254-61.
31. Ichiyama T, Sakai T, Catania A, et al. Inhibition of peripheral NF-kappaB activation by central action of alpha-melanocyte-stimulating hormone. J Neuroimmunol 1999;99:211-17.
32. Scholzen TE, Sunderkotter C, Kalden DH, et al. Alpha-melanocyte stimulating hormone prevents lipopolysaccharide-induced vasculitis by down-regulating endothelial cell adhesion molecule expression. Endocrinology 2003;144:360-70.
33. Luger TA, Scholzen TE, Brzoska T, et al. New insights into the functions of alpha-MSH and related peptides in the immune system. Ann NY Acad Sci 2003;994:133-40.
34. Lipton JM, Catania A. Mechanisms of antiinflammatory action of the neuroimmunomodulatory peptide alpha-MSH. Ann NY Acad Sci 1998;840:373-80.
35. Taherzadeh S, Sharma S, Chhajlani V, et al. alpha-MSH and its receptors in regulation of tumor necrosis factor-alpha production by human monocyte/macrophages. Am J Physiol 1999;276:R1289-94.
36. Robbins LS, Nadeau JH, Johnson KR, et al. Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 1993;72:827-34.
37. Maaser C, Housley MP, Iimura M, et al. Clearance of Citrobacter rodentium requires B cells but not secretory immunoglobulin A (IgA) or IgM antibodies. Infect Immun 2004;72:3315-24.
38. Branson R, Potoczna N, Kral JG, et al. Binge eating as a major phenotype of melanocortin 4 receptor gene mutations. N Engl J Med 2003;348:1096-103.
39. Huszar D, Lynch CA, Fairchild-Huntress V, et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997;88:131-41.
40. Getting SJ, Schioth HB, Perretti M. Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides. J Pharmacol Exp Ther 2003;306:631-7.
41. Hiltz ME, Lipton JM. Antiinflammatory activity of a COOH-terminal fragment of the neuropeptide alpha-MSH. FASEB J 1989;3:2282-4.
42. Szardenings M, Muceniece R, Mutule I, et al. New highly specific agonistic peptides for human melanocortin MC(1) receptor. Peptides 2000;21:239-43.
43. Slominski A, Plonka PM, Pisarchik A, et al. Preservation of eumelanin hair pigmentation in proopiomelanocortin-deficient mice on a nonagouti (a/a) genetic background. Endocrinology 2005;146:1245-53.
44. Smith R, Healy E, Siddiqui S, et al. Melanocortin 1 receptor variants in an Irish population. J Invest Dermatol 1998;111:119-22.
45. Healy E, Flannagan N, Ray A, et al. Melanocortin-1-receptor gene and sun sensitivity in individuals without red hair. Lancet 2000;355:1072-3.
46. Flanagan N, Healy E, Ray A, et al. Pleiotropic effects of the melanocortin 1 receptor (MC1R) gene on human pigmentation. Hum Mol Genet 2000;9:2531-7.
47. Palmer JS, Duffy DL, Box NF, et al. Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am J Hum Genet 2000;66:176-86.
48. Kennedy C, ter Huurne J, Berkhout M, et al. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol 2001;117:294-300.
49. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.
50. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-6.